Johan Bjorkegren, MD, PhD
img_Johan Bjorkegren
CLINICAL PROFESSOR | Genetics and Genomic Sciences
Multi-Disciplinary Training Area
Genetics and Genomic Sciences [GGS]

MD, Karolinska University Hospital

PhD, Karolinska Institutet

Publications

Selected Publications

Integrative gene regulatory network analysis discloses key driver genes of fibromuscular dysplasia. Valentina d’Escamard, Daniella Kadian-Dodov, Lijiang Ma, Sizhao Lu, Annette King, Yang Xu, Shouneng Peng, Bhargravi V′Gangula, Yu Zhou, Allison Thomas, Katherine C. Michelis, Emir Bander, Rihab Bouchareb, Adrien Georges, Aya Nomura-Kitabayashi, Robert J. Wiener, Kevin D. Costa, Elena Chepurko, Vadim Chepurko, Marika Fava, Temo Barwari, Anelechi Anyanwu, Farzan Filsoufi, Sander Florman, Nabila Bouatia-Naji, Lukas E. Schmidt, Manuel Mayr, Michael G. Katz, Ke Hao, Mary C.M. Weiser-Evans, Johan L.M. Björkegren, Jeffrey W. Olin, Jason C. Kovacic. Nature Cardiovascular Research

Systems genetics analysis of human body fat distribution genes identifies adipocyte processes. Jordan N. Reed, Jiansheng Huang, Yong Li, Lijiang Ma, Dhanush Banka, Martin Wabitsch, Tianfang Wang, Wen Ding, Johan L.M. Björkegren, Mete Civelek. Life Science Alliance

Single-Cell Gene-Regulatory Networks of Advanced Symptomatic Atherosclerosis. Giuseppe Mocci, Katyayani Sukhavasi, Tiit Ord, Sean Bankier, Prosanta Singha, Uma Thanigai Arasu, Olayinka Oluwasegun Agbabiaje, Petri Makinen, Lijiang Ma, Chani J. Hodonsky, Redouane Aherrahrou, Lars Muhl, Jianping Liu, Sonja Gustafsson, Byambajav Byandelger, Ying Wang, Simon Koplev, Urban Lendahl, Gary K. Owens, Nicholas J. Leeper, Gerard Pasterkamp, Michael Vanlandewijck, Tom Michoel, Arno Ruusalepp, Ke Hao, Seppo Yla-Herttuala, Marika Vali, Heli Jarve, Michal Mokry, Mete Civelek, Clint J. Miller, Jason C. Kovacic, Minna U. Kaikkonen, Christer Betsholtz, Johan L.M. Bjorkegren. Circulation Research

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Bjorkegren during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

  • Clinical Gene Networks AB

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Clinical Gene Networks AB

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Clinical Gene Networks AB

Founder/Co-Founder/Partner

  • Clinical Gene Networks AB

Outside Employment

  • Karolinska Institute

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.